These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 669840)

  • 41. Muscle protein metabolism during hemodialysis.
    Bohé J; Rennie MJ
    J Ren Nutr; 2006 Jan; 16(1):3-16. PubMed ID: 16414436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial Brazilian experience with short-duration in-center daily hemodialysis.
    Lugon JR; Andre MB
    Hemodial Int; 2005 Jan; 9(1):3-6. PubMed ID: 16191048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein and energy: recommended intake and nutrient supplementation in chronic dialysis patients.
    Ikizler TA
    Semin Dial; 2004; 17(6):471-8. PubMed ID: 15660578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presence of insulin-renin-aldosterone-potassium interrelationship in normal subjects, disrupted in chronic hemodialysis patients.
    Farfel Z; Iaina A; Eliahou HE
    J Clin Endocrinol Metab; 1978 Jul; 47(1):9-17. PubMed ID: 400716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Allstate scientific conference on metabolism in uremia and on the therapy of renal insufficiency using hemodialysis].
    Horák J
    Vnitr Lek; 1970 Jul; 16(7):718-20. PubMed ID: 5456660
    [No Abstract]   [Full Text] [Related]  

  • 46. Oxidative stress and uremia.
    Floccari F; Aloisi C; Crascì E; Sofi T; Campo S; Tripodo D; Criseo M; Frisina N; Buemi M
    Med Res Rev; 2005 Jul; 25(4):473-86. PubMed ID: 15660443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Life threatening hypokalemia during hemodialysis.
    Wiegand C; Davin T; Raij L; Kjellstrand C
    Trans Am Soc Artif Intern Organs; 1979; 25():416-8. PubMed ID: 524615
    [No Abstract]   [Full Text] [Related]  

  • 48. Acid base balance in chronic hemodialysis.
    Earnest DL; Sadler JH; Ingram RH; Macon EJ
    Trans Am Soc Artif Intern Organs; 1968; 14():434-9. PubMed ID: 5701568
    [No Abstract]   [Full Text] [Related]  

  • 49. [Changes in membrane sodium transport and arterial hypertension in uremic patients under dialysis].
    Quarello F; Boero R; Guarena C; Berto I; Colombo P; Beltrame G; Piccoli G
    Minerva Urol Nefrol; 1988; 40(3):207-10. PubMed ID: 2853454
    [No Abstract]   [Full Text] [Related]  

  • 50. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 51. Resting skeletal muscle membrane potential as an index of uremic toxicity. A proposed new method to assess adequacy of hemodialysis.
    Cotton JR; Woodard T; Carter NW; Knochel JP
    J Clin Invest; 1979 Mar; 63(3):501-6. PubMed ID: 429569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The abnormalities of carbohydrate and lipid metabolism in uremia. A study in 20 hemodialyzed patients (author's transl)].
    Prinseau J; Meyrier A; Domart M; Brault D; Ragot J; Etienne J
    Sem Hop; 1980 Oct; 56(37-38):1491-6. PubMed ID: 6254168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid metabolism in dialysis patients-the story gets more complicated.
    Ponda MP; Barash I
    Semin Dial; 2008; 21(5):390-4. PubMed ID: 18764791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cardiac rhythm disorders in patients with chronic renal insufficiency treated with repeated hemodialysis].
    Sumarokov AV; Ermolenko VM; Lifshits NL; Mikhaĭlov AA; Chegaev VA
    Kardiologiia; 1971 Feb; 11(2):59-66. PubMed ID: 5568393
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical results of intermittent dialysis therapy (IDT) guided by ongoing kinetic analysis of urea metabolism.
    Gotch FA; Sargent JA; Keen M; Lam M; Prowitt M; Grady M
    Trans Am Soc Artif Intern Organs; 1976; 22():175-89. PubMed ID: 181887
    [No Abstract]   [Full Text] [Related]  

  • 56. [Vitamin K1 and C metabolism in uremia during hemodialysis].
    Bakaev VV; Khomenko VF
    Urol Nefrol (Mosk); 1991; (1):40-3. PubMed ID: 1858205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure.
    Hayes CP; McLeod ME; Robinson RR
    Trans Assoc Am Physicians; 1967; 80():207-16. PubMed ID: 6082243
    [No Abstract]   [Full Text] [Related]  

  • 58. [Protective role of carnitine in acetate metabolism of patients with uremia treated by hemodialysis].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1997 Jun; 97(6):534-40. PubMed ID: 9441289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of acid-base balance and pO2 with acetate dialysis in non-uremic patients.
    Taccone-Gallucci M; Mazzarella V; Morosetti M; Verardi S; Meloni C; Verardi V; Matteucci MC; Boffo V; Torregrossa G; Casciani CU
    Int J Artif Organs; 1982 May; 5(3):145-7. PubMed ID: 7107048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.